Neurostimulation Devices Market Size

  • Report ID: 4239
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Neurostimulation Devices Market Outlook:

Neurostimulation Devices Market size was valued at USD 8.23 billion in 2025 and is likely to cross USD 26.02 billion by 2035, expanding at more than 12.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of neurostimulation devices is assessed at USD 9.13 billion.

The market is estimated to grow on the back of increasing neurological surgeries and disorders. According to estimates, about 22 million people suffer from neurological disorders every year, of which 13 million require surgery.  Moreover, an increasing number of minimally invasive surgeries across the globe is also anticipated to fuel the growth of the market in the coming years. Additionally, increasing the adoption of neurostimulation devices for the treatment of neurological disorders and increasing patient awareness are also expected to boost the growth of the global market during the forecast period.

The global neurostimulation devices market is also estimated to witness growth on account of the increasing level of the geriatric population globally. According to the World Health Organization (WHO) data, the population aged 60 years and above stood at around 1 billion in 2020, which is projected to reach 1.4 billion by the end of 2030.  According to the World Health Organization (WHO) data, the population of people aged 60 years and above in China was around 254 million in 2019, with about 176 million people aged 65 and above. By 2040, it is estimated that there will be about 402 million people over the age of 60 in China. Moreover, the increasing technological advancement and innovation in these neurostimulation devices are anticipated to drive market growth during the forecast period.


Neurostimulation Devices Market

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of neurostimulation devices is assessed at USD 9.13 billion.

The global neurostimulation devices market size was valued at over USD 8.23 billion in 2025 and is expected to expand at a CAGR of around 12.2%, surpassing USD 26.02 billion revenue by 2035.

North America’s neurostimulation devices market dominates with a 58.7% share by 2035, driven by rising prevalence of neurological disorders, a growing geriatric population, and increasing adoption of implantable neurostimulation devices.

Key players in the market include Abbott Laboratories, Boston Scientific Corporation, Integer Holdings Corporation, Medtronic, Nevro Corp., NeuroSigma, Inc., NeuroPace, Inc., Neuronetics, Synapse Biomedical Inc., Soterix Medical, Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos